By using human X-ALD fibroblasts and a zebrafish Abcd1 mutant model, metabolic rerouting of saturated to monounsaturated VLCFAs by SCD1 was found to attenuate lipid toxicity (Fig. 1) [19]. The gene discussed is SCD; the disease is X-linked adrenoleukodystrophy.